Disulfide bonds determine growth hormone receptor folding, dimerisation and ligand binding

Journal of Cell Science

Volumn 119, Issue 15, 2006, Pages 3078-3086

  van den Eijnden, Monique J M ^a   Lahaye, Liza L ^a   Strous, Ger J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Cytokine receptor; Dimerisation; Disulfide bonds; ER; Folding; Growth hormone

Indexed keywords

DIMER; GROWTH HORMONE RECEPTOR; MUTANT PROTEIN;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; BINDING AFFINITY; CELL SURFACE; CONTROLLED STUDY; DIMERIZATION; DISULFIDE BOND; HORMONE BINDING; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN PROCESSING; SIGNAL TRANSDUCTION; WILD TYPE;

ANIMALS; DIMERIZATION; DISULFIDES; LIGANDS; MODELS, MOLECULAR; MUTATION; PROTEIN CONFORMATION; PROTEIN FOLDING; RABBITS; RECEPTORS, SOMATOTROPIN; SIGNAL TRANSDUCTION;

EID: 33748309115     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.03036     Document Type: Article

References (41)

1. Argetsinger, L. S. and Carter-Su, C. (1996). Mechanism of signaling by growth hormone receptor. Physiol. Rev. 76, 1089-1107.
2. Argetsinger, L. S., Campbell, G. S., Yang, X. N., Witthuhn, B. A., Silvennoinen, O., Ihle, J. N. and Carter-Su, C. (1993). Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase. Cell 74, 237-244.
3. Bass, S. H., Mulkerrin, M. G. and Wells, J. A. (1991). A systematic mutational analysis of hormone-binding determinants in the human growth hormone receptor. Proc. Natl. Acad Sci. USA 88, 4498-4502.
4. Baumann, G. (2001). Growth hormone binding protein 2001. J. Pediatr. Endocrinol. Metab. 14,355-375.
5. Bazan, J. F. (1990). Structural design and molecular evolution of a cytokine receptor superfarmily. Proc. Natl. Acad. Sci. USA 87, 6934-6938.
6. Bentham, J., Aplin, R. and Norman, M. R. (1994). Histochemical detection of binding sites for human growth hormone using biotinylated ligand. J Histochem. Cytochem. 42, 103-107.
7. Brodsky, J. L. and McCracken, A. A. (1999). ER protein quality control and proteasome-mediated protein degradation. Semin. Cell Dev. Biol. 10, 507-513.
8. Brown, R. J., Adams, J. J., Pelekanos, R. A., Wan, Y., McKinstry, W. J., Palethorpe, K., Seeber, R. M., Monks, T. A., Eidne, K. A., Parker, M. W. et a]. (2005). Model for growth hormone receptor activation based on subunit rotation within a receptor dimer. Nat. Struct. Mol. Biol. 12, 814-821.
9. Chen, C., Brinkworth, R. and Waters, M. J. (1997). The role of receptor dimerization domain residues in growth hormone signaling. J. Biol. Chem. 272, 5133-5140.
10. Conte, F., Salles, J. P., Raynal, P., Fernandez, L., Molinas, C., Tauber, M. and Bieth, E. (2002). Identification of a region critical for proteolysis of the human growth hormone receptor. Biochem. Biophys. Res. Commun. 290, 851-857.
11. Cowan, J. W., Wang, X., Goan, R., He, K., Jiang, J., Baumann, G., Black, R. A., Wolfe, M. S. and Frank, S. J. (2005). Growth hormone receptor is a target for presenilin-dependent {gamma}-secretase cleavage. J Biol. Chem 280, 19331-19342.
12. Cunningham, B. C., Ultsch, M., De Vos, A. M., Mulkerrin, M. G., Clauser, K. R. and Wells, J. A. (1991). Dimerization of the extracellular domain of the human growth hormone receptor by a single hormone molecule. Science 254, 821-825.
13. de Vos, A. M., Ultsch, M. and Kossiakoff, A. A. (1992). Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. Science 255, 306-312.
14. Frank, S. J., Gilliland, G., Kraft, A. S. and Arnold, C. S. (1994). Interaction of the growth hormone receptor cytoplasmic domain with the JAK2 tyrosine kinase. Endocrinology 135, 2228-2239.
15. Fuh, G., Mulkerrin, M. G., Bass, S., McFarland, N., Brochier, M., Bourell, J. H., Light, D. R. and Wells, J. A. (1990). The human growth hormone receptor. Secretion from Escherichia coli and disulfide bonding pattern of the extracellular domain. J. Biol. Chem. 265, 3111-3115.
16. Fukada, H., Ozaki, Y., Pierce, A. L., Adachi, S., Yamauchi, K., Hara, A., Swanson, P. and Dickhoff, W. W. (2004). Salmon growth hormone receptor: molecular cloning, ligand specificity, and response to fasting. Gen. Comp. Endocrinol. 139, 61-71.
17. Gent, J., van Kerkhof, P., Roza, M., Bu, G. and Strous, G. J. (2002). Ligand-independent growth hormone receptor dimerization occurs in the endoplasmic reticulum and is required for ubiquitin system-dependent endocytosis. Proc. Natl. Acad. Sci. USA 99, 9858-9863.
18. Gent, J., van den Eijnden, M., van Kerkhof, P. and Strous, G. J. (2003). Dimerization and signal transduction of the growth hormone receptor. Mol. Endocrinol. 17, 967-975.
19. Govers, R., ten Broeke, T., van Kerkhof, P., Schwartz, A. L. and Strous, G. J. (1999). Identification of a novel ubiquitin conjugation motif, required for ligand-induced internalization of the growth hormone receptor. EMBO J. 18, 28-36.
20. Grotzinger, J. (2002). Molecular mechanisms of cytokine receptor activation. Biochim. Biophys. Acta 1592, 215-223.
21. Harding, P. A., Wang, X. Z., Kelder, B., Souza, S., Okada, S. and Kopchick, J. J. (1994). In vitro mutagenesis of growth hormone receptor Asn-linked glycosylation sites. Mol. Cell Endocrinol. 106, 171-180.
22. Jansens, A. and Braakman, I. (2003). Pulse-chase labeling techniques for the analysis of protein maturation and degradation. Methods Mol. Biol. 232, 133-146.
23. Laron, Z., Pertzelan, A., Karp, M., Kowadlo-Silbergeld, A. and Daughaday, W. H. (1971). Administration of growth hormone to patients with familial dwarfism with high plasma immunoreactive growth hormone: measurement of sulfation factor, metabolic and linear growth responses. J Clin. Endocrinol. Metab. 33, 332-342.
24. Leung, D. W., Spencer, S. A., Cachianes, G., Hammonds, R. G., Collins, C., Henzel, W. J., Barnard, R., Waters, M. J. and Wood, W. J. (1987). Growth hormone receptor and serum binding protein: purification, cloning and expression. Nature 330, 537-543.
25. Meusser, B., Hirsch, C., Jarosch, E. and Sommer, T. (2005). ERAD: the long road to destruction. Nat. Cell Biol. 7, 766-772.
26. Ross, R. J., Leung, K. C., Maamra, M., Bennett W., Doyle, N., Waters, M. J. and Ho, K. K. (2001). Binding and functional studies with the growth hormone receptor antagonist, B2036-PEG (Pegvisomant), reveal effects of pegylation and evidence that it binds to a receptor dimer. J Clin. Endocrinol. Metab. 86, 1716-1723.
27. Sachse, M., van Kerkhof, P., Strous, G. J. and Klumperman, J. (2001). The ubiquitin-dependent endocytosis motif is required for efficient incorporation of growth hormone receptor in clathrin-coated pits, but not clathrin-coated lattices. J. Cell Sci. 114, 3943-3952.
28. Sachse, M., Urbe, S., Oorschot, V., Strous, G. J. and Klumperman, J. (2002). Bilayered clathrin coats on endosomal vacuoles are involved in protein sorting toward lysosomes. Mol. Biol. Cell 13, 1313-1328.
29. Schantl, J. A., Roza, M., Van Kerkhof, P. and Strous, G. J. (2003). The growth hormone receptor interacts with its sheddase, the tumour necrosis factor-alpha converting enzyme (TACE). Biochem. J. 377, 379-384.
30. Sobrier, M. L., Dostat, F., Duquesnoy, P., Kandemir, N., Yordam, N., Goossens, M. and Amselem, S. (1997). Nine novel growth hormone receptor gene mutations in patients with Laron syndrome. J. Clin. Endocrinol. Metab. 82, 435-437.
31. Sommer, T. and Wolf, D. H. (1997). Endoplasmic reticulum degradation: reverse protein flow of no return. FASEB J. 11, 1227-1233.
32. Sotiropoulos, A., Perrot-Applanat, M., Dinerstein, H., Pallier, A., Postel-Vinay, M. C., Finidori, J. and Kelly, P. A. (1994). Distinct cytoplasmic regions of the growth hormone receptor are required for activation of JAK2, mitogen-activated protein kinase, and transcription. Endocrinology 135, 1292-1298.
33. Strous, G. J., van Kerkhof, P., Govers, R., Ciechanover, A. and Schwartz, A. L. (1996). The ubiquitin conjugation system is required for ligand-induced endocytosis and degradation of the growth hormone receptor. EMBO J. 15, 3806-3812.
34. Szecowka, J., Tai, L. R. and Goodman, H. M. (1990). Effects of tunicamycin on growth hormone binding in rat adipocytes. Endocrinology 126, 1834-1841.
35. van Kerkhof, P. and Strous, G. J. (200t). The ubiquitin-proteasome pathway regulates lysosomal degradation of the growth hormone receptor and its ligand. Biochem. Soc. Trans. 29, 488-493.
36. van Kerkhof, P., Govers, R., Alves dos Santos, C. M. and Strous, G. J. (2000). Endocytosis and degradation of the growth hormone receptor are proteasome-dependent. J. Biol. Chem. 275, 1575-1580.
37. van Kerkhof, P., Alves dos Santos, C. M., Sachse, M., Klumperman, J., Bu, G. and Strous, G. J. (2001a). Proteasome inhibitors block a late step in lysosomal transport of selected membrane but not soluble proteins. Mol. Biol. Cell 12, 2556-2566.
38. van Kerkhof, P., Sachse, M., Klumperman, J. and Strous, G. J. (2001b). Growth hormone receptor ubiquitination coincides with recruitment to clathrin-coated membrane domains. I Biol. Chem 276, 3778-3784.
39. van Kerkhof, P., Smeets, M. and Strous, G. J (2002). The ubiquitin-proteasome pathway regulates the availability of the GH receptor. Endocrinology 143, 1243-1252.
40. Zhang, Y., Jiang, J., Kopchick, J. J. and Frank, S. J. (1999). Disulfide linkage of growth hormone (GH) receptors (GHR) reflects GH-induced GHR dimerization-association of JAK2 with the GHR is enhanced by receptor dimerization. J. Biol. Chem. 274, 33072-33084.
41. Zhang, Y., Jiang, J., Black, R. A., Baumann, G. and Frank, S. J. (2000). Tumor necrosis factor-alpha converting enzyme (TACE) is a growth hormone binding protein (GHBP) sheddase: the metalloprotease TACE/ADAM-17 is critical for (PMA-induced) GH receptor proteolysis and GHBP generation. Endocrinology 141, 4342-4348.